Keyphrases
Transcription Factor
100%
B Cells
100%
Epstein-Barr Virus Infections
100%
C-Jun
100%
B Lymphocytes
100%
Latent Membrane Protein 1 (LMP1)
100%
Activating Transcription Factor 2 (ATF2)
100%
Chronic Lymphocytic Leukemia Cells
100%
Epstein-Barr Virus
83%
Histone Deacetylase Inhibitor (HDACi)
33%
Nuclear Antigen 2
33%
Phorbol 12
33%
Virus
16%
Viral
16%
Infectious Mononucleosis
16%
Cellular Proteins
16%
Nuclear Proteins
16%
Immunocompromised Patients
16%
Butyrate
16%
Virus Receptor
16%
Infected Cells
16%
Chronic Lymphocytic Leukemia
16%
Subsequent Therapy
16%
Lymphoid Tissue
16%
CD40 Ligand (CD40L)
16%
Interaction Partner
16%
CD21
16%
Lymphoproliferation
16%
Specific Sequences
16%
Ex-vivo Samples
16%
Medicine and Dentistry
B Cell
100%
Epstein-Barr Virus Infection
100%
B Lymphocyte
100%
Leukemia Cell
100%
B-Cell Chronic Lymphocytic Leukemia
100%
Latent Membrane Protein 1
100%
Activating Transcription Factor 2
100%
Epstein Barr Virus
83%
In Vitro
33%
Histone Deacetylase Inhibitor
33%
Phorbol Dibutyrate
33%
Promoter Region
16%
Infectious Mononucleosis
16%
Butyric Acid
16%
Nuclear Protein
16%
Cell Nucleus Antigen
16%
Lymphocyte Proliferation
16%
Lymphatic Tissue
16%
Ex Vivo
16%
CD40 Ligand
16%
Epstein Barr Virus Antigen 2
16%
Cell Protein
16%
Virus Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein Barr Virus Infection
100%
Epstein-Barr Virus Latent Membrane Protein 1
100%
Chronic Lymphatic Leukemia
100%
Activating Transcription Factor 2
100%
Epstein-Barr Virus
66%
Histone Deacetylase Inhibitor
33%
Phorbol 12,13-dibutyrate
33%
Cell Protein
16%
Butyrate
16%
CD40 Ligand
16%
Nuclear Protein
16%
Cell Nucleus Antigen
16%
Mononucleosis
16%
Virus Receptor
16%
Epstein-Barr Virus Nuclear Antigen 2
16%
Immunology and Microbiology
B Cell
100%
Viral Disease
100%
Leukemia Cell
100%
Activating Transcription Factor 2
100%
Epstein Barr Virus
100%
Epstein-Barr Virus Latent Membrane Protein 1
75%
Mononucleosis
12%
Promoter Region
12%
Cell Nucleus Antigen
12%
Lymphocyte Proliferation
12%
Lymphoid Tissue
12%
CD40 Ligand
12%
Epstein-Barr Virus Nuclear Antigen 2
12%